Literature DB >> 11114252

Structure-activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI.

A P Golovanov1, T H Chuang, C DerMardirossian, I Barsukov, D Hawkins, R Badii, G M Bokoch, L Y Lian, G C Roberts.   

Abstract

The guanine dissociation inhibitors RhoGDI and D4GDI inhibit guanosine 5'-diphosphate dissociation from Rho GTPases, keeping these small GTPases in an inactive state. The GDIs are made up of two domains: a flexible N-terminal domain of about 70 amino acid residues and a folded 134-residue C-terminal domain. Here, we characterize the conformation of the N-terminal regions of both RhoGDI and D4GDI using a series of NMR experiments which include (15)N relaxation and amide solvent accessibility measurements. In each protein, two regions with tendencies to form helices are identified: residues 36 to 58 and 9 to 20 in RhoGDI, and residues 36 to 57 and 20 to 25 in D4GDI. To examine the functional roles of the N-terminal domain of RhoGDI, in vitro and in vivo functional assays have been carried out with N-terminally truncated proteins. These studies show that the first 30 amino acid residues are not required for inhibition of GDP dissociation but appear to be important for GTP hydrolysis, whilst removal of the first 41 residues completely abolish the ability of RhoGDI to inhibit GDP dissociation. The combination of structural and functional studies allows us to explain why RhoGDI and D4GDI are able to interact in similar ways with the guanosine 5'-diphosphate-bound GTPase, but differ in their ability to regulate GTP-bound forms; these functional differences are attributed to the conformational differences of the N-terminal domains of the guanosine 5'-diphosphate dissociation inhibitors. Therefore, the two transient helices, appear to be associated with different biological effects of RhoGDI, providing a clear example of structure-activity relationships in a flexible protein domain. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11114252     DOI: 10.1006/jmbi.2000.4262

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  23 in total

1.  Quantitative analysis of prenylated RhoA interaction with its chaperone, RhoGDI.

Authors:  Zakir Tnimov; Zhong Guo; Yann Gambin; Uyen T T Nguyen; Yao-Wen Wu; Daniel Abankwa; Anouk Stigter; Brett M Collins; Herbert Waldmann; Roger S Goody; Kirill Alexandrov
Journal:  J Biol Chem       Date:  2012-05-24       Impact factor: 5.157

2.  RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells.

Authors:  Takahide Ota; Masayo Maeda; Shiho Sakita-Suto; Xinwen Zhou; Manabu Murakami; Tsutomu Takegami; Masaaki Tatsuka
Journal:  Clin Exp Metastasis       Date:  2006-11-17       Impact factor: 5.150

3.  Concordance and interaction of guanine nucleotide dissociation inhibitor (RhoGDI) with RhoA in oogenesis and early development of the sea urchin.

Authors:  Vanesa Zazueta-Novoa; Guadalupe Martínez-Cadena; Gary M Wessel; Roberto Zazueta-Sandoval; Laura Castellano; Jesús García-Soto
Journal:  Dev Growth Differ       Date:  2011-04       Impact factor: 2.053

4.  A novel inhibitor of Rho GDP-dissociation inhibitor α improves the therapeutic efficacy of paclitaxel in Lewis lung carcinoma.

Authors:  Xing Chen Peng; Xu Xia Chen; Y U Zhang; Hai Jun Wang; You Feng
Journal:  Biomed Rep       Date:  2015-05-27

5.  A proteomic investigation into adriamycin chemo-resistance of human leukemia K562 cells.

Authors:  Xingchen Peng; Fengming Gong; Gang Xie; Yuwei Zhao; Minghai Tang; Luoting Yu; Aiping Tong
Journal:  Mol Cell Biochem       Date:  2011-01-18       Impact factor: 3.396

Review 6.  The Rho GTPase signalling pathway in urothelial carcinoma.

Authors:  Solomon L Woldu; Ryan C Hutchinson; Laura-Maria Krabbe; Oner Sanli; Vitaly Margulis
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

Review 7.  RhoGDI: multiple functions in the regulation of Rho family GTPase activities.

Authors:  Athanassios Dovas; John R Couchman
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

8.  Rictor encounters RhoGDI2: the second pilot is taking a lead.

Authors:  Nitin K Agarwal; Dubek Kazyken; Dos D Sarbassov
Journal:  Small GTPases       Date:  2013-01-25

9.  ZAK negatively regulates RhoGDIbeta-induced Rac1-mediated hypertrophic growth and cell migration.

Authors:  Chih-Yang Huang; Li-Chiu Yang; Kuan-Yu Liu; I-Chang Chang; Pao-Hsin Liao; Janet Ing-Yuh Chou; Ming-Yung Chou; Wei-Wen Lin; Jaw-Ji Yang
Journal:  J Biomed Sci       Date:  2009-06-18       Impact factor: 8.410

10.  Protein expression in human trabecular meshwork: downregulation of RhoGDI by dexamethasone in vitro.

Authors:  Minbin Yu; Jing Sun; Wei Peng; Ziyan Chen; Xianchai Lin; Xuyang Liu; Mingtao Li; Kaili Wu
Journal:  Mol Vis       Date:  2010-02-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.